120 related articles for article (PubMed ID: 17047397)
21. Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas.
Oh JE; Kim MS; Ahn CH; Kim SS; Han JY; Lee SH; Yoo NJ
Pathology; 2010 Jan; 42(1):73-6. PubMed ID: 20025484
[TBL] [Abstract][Full Text] [Related]
22. Mutational analysis of caspase-14 gene in common carcinomas.
Yoo NJ; Soung YH; Lee SH; Jeong EG; Lee SH
Pathology; 2007 Jun; 39(3):330-3. PubMed ID: 17558860
[TBL] [Abstract][Full Text] [Related]
23. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma.
Flatley E; Ang D; Warrick A; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2013 Jul; 44(7):1320-7. PubMed ID: 23352210
[TBL] [Abstract][Full Text] [Related]
24. Mutational analysis of caspase 1, 4, and 5 genes in common human cancers.
Soung YH; Jeong EG; Ahn CH; Kim SS; Song SY; Yoo NJ; Lee SH
Hum Pathol; 2008 Jun; 39(6):895-900. PubMed ID: 18430458
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias.
Lee SH; Jeong EG; Yoo NJ; Lee SH
APMIS; 2007 Dec; 115(12):1357-63. PubMed ID: 18184405
[TBL] [Abstract][Full Text] [Related]
26. Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma.
Dunlap J; Le C; Shukla A; Patterson J; Presnell A; Heinrich MC; Corless CL; Troxell ML
Breast Cancer Res Treat; 2010 Apr; 120(2):409-18. PubMed ID: 19418217
[TBL] [Abstract][Full Text] [Related]
27. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
28. Somatic mutations of BECN1, an autophagy-related gene, in human cancers.
Lee JW; Jeong EG; Lee SH; Yoo NJ; Lee SH
APMIS; 2007 Jun; 115(6):750-6. PubMed ID: 17550384
[TBL] [Abstract][Full Text] [Related]
29. Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers.
An CH; Kim MS; Yoo NJ; Park SW; Lee SH
Pathol Res Pract; 2011 Jul; 207(7):433-7. PubMed ID: 21664058
[TBL] [Abstract][Full Text] [Related]
30. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
Iamaroon A; Krisanaprakornkit S
Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
[TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of the CASP6 gene in colorectal and gastric carcinomas.
Lee JW; Kim MR; Soung YH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
APMIS; 2006 Sep; 114(9):646-50. PubMed ID: 16948818
[TBL] [Abstract][Full Text] [Related]
32. Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
Levine DA; Bogomolniy F; Yee CJ; Lash A; Barakat RR; Borgen PI; Boyd J
Clin Cancer Res; 2005 Apr; 11(8):2875-8. PubMed ID: 15837735
[TBL] [Abstract][Full Text] [Related]
33. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
[TBL] [Abstract][Full Text] [Related]
34. Mutations of p53 gene in gastric carcinoma in Taiwan.
Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
[TBL] [Abstract][Full Text] [Related]
35. K-Ras(V12) differentially affects the three Akt isoforms in lung and pancreatic carcinoma cells and upregulates E-cadherin and NCAM via Akt3.
Geißert R; Lammert A; Wirth S; Hönig R; Lohfink D; Unger M; Pek D; Schlüter K; Scheftschik T; Smit DJ; Jücker M; Menke A; Giehl K
Cell Commun Signal; 2024 Jan; 22(1):85. PubMed ID: 38291468
[TBL] [Abstract][Full Text] [Related]
36. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
Yoo NJ; Park SW; Lee SH
Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
[TBL] [Abstract][Full Text] [Related]
37. Life with a single isoform of Akt: mice lacking Akt2 and Akt3 are viable but display impaired glucose homeostasis and growth deficiencies.
Dummler B; Tschopp O; Hynx D; Yang ZZ; Dirnhofer S; Hemmings BA
Mol Cell Biol; 2006 Nov; 26(21):8042-51. PubMed ID: 16923958
[TBL] [Abstract][Full Text] [Related]
38. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice.
Maroulakou IG; Oemler W; Naber SP; Tsichlis PN
Cancer Res; 2007 Jan; 67(1):167-77. PubMed ID: 17210696
[TBL] [Abstract][Full Text] [Related]
39. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
Kehr EL; Jorns JM; Ang D; Warrick A; Neff T; Degnin M; Lewis R; Beadling C; Corless CL; Troxell ML
Hum Pathol; 2012 Dec; 43(12):2207-12. PubMed ID: 22705004
[TBL] [Abstract][Full Text] [Related]
40. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
